- SK Hynix: The specific shareholder return plan will be shared with the market before the end of the year. The company believes it can significantly expand shareholder returns.
- US July ADP employment increased by 44,000, lower than expected and previous values.
- Memory shortages may persist until 2027! Samsung, SK Hynix, and Micron's production capacity sold out in advance
- HBAR Inks Landmark Deal: The $5.4T Opportunity Is Here
- Kashkari: I would rather take small steps now than wait.
- US AI cloud computing company Coreweave (CRWV.US) has signed a multi-year agreement with data storage solutions provider Solidigm.
- Sources say there have been no discussions regarding a potential deal between AstraZeneca (AZN.US) and Bristol-Myers Squibb (BMY.US).
- US AI cloud computing company COREWEAVE (CRWV.US): The agreement with Solidigm will strengthen its integrated artificial intelligence platform.
- Ethereum Proposal Would Burn Staking Rewards to Zero if Half of ETH Is Staked
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- Southwest Gas 2Q Adj EPS 45c >SWX
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Gold and Silver Price Outlook: Precious Metals in Focus During Nonfarm Payrolls Week, Gold Tests Key Breakout Level
- Southwest Gas Sees 2026- 2030 Cap Expenditures $6.3 B >SWX
- Southwest Gas Sees 2026 Cap Expenditures About $1.25 B >SWX
- Southwest Gas Backs 2026 Cont Ops EPS $4.17-EPS $4.32 >SWX
- Correct: Global Indemnity 2Q Expense Ratio 41.2% >GBLI
- Spot silver has just reached the $62.00/oz mark, now quoted at $62.00/oz, up 4.21% on the day; main COMEX silver futures are now quoted at $62.26/oz, up 3.34% on the day.
- Spot gold has just broken through the $4,190.00/oz mark, now quoted at $4,190.08/oz, up 2.77% on the day; COMEX gold futures main contract is now quoted at $4,249.60/oz, up 2.34% on the day.
- SpaceX Surprises Wall Street With Better-than-expected Results
- Global Indemnity 2Q Operating EPS 59c >GBLI
- ImageneBio Sees Cash Runway Funding Planned Ops Into 1Q of 2028 >IMA
- One Stop Systems Raises 2026 Rev Growth to 25%-30% >OSS
- Avnet Sees 1Q Adj EPS $2.80-Adj EPS $2.90 >AVT
- Global Ship Lease 2Q Adj EPS $2.48 >GSL
- XRP Collateral Supply Shock Loading. Here’s What Is Happening
- Bitcoin lags as global equities reach record highs
- Pump.fun buys back 332M PUMP – Rally continues ONLY IF…
- B&G Foods: New CEO Has Accepted Role but Remains Unnamed >BGS
- SmartRent 2Q Rev $39.8M >SMRT
- Global Ship Lease 2Q EPS $2.48 >GSL
- One Stop Systems 2Q Loss/Shr 29c >OSS
- One Stop Systems 2Q Rev $9.35M >OSS
- Icahn Enterprises Indicative Net Asset Value Was $2.6B as of June 30 >IEP
- Avnet Sees 1Q Sales $9B-$9.3B >AVT
- Atlanta Braves Holdings 2Q Loss/Shr 19c >BATRA
- Karat Packaging Raises Dividend to 47c >KRT
- Atlanta Braves Holdings 2Q Rev $305.1M >BATRA
- ImageneBio 2Q Loss/Shr 63c >IMA
- B&G Foods Keller's Retirement Effective Aug. 7 >BGS
- Trinity Capital 2Q Net Investment Income $46.0M or 51c/Shr >TRIN
- Rand Capital Net Asset Value Per Shr Was $17.33 at June 30 >RAND
- Correct: B&G Foods: CEO Kenneth Keller to Retire >BGS
- Visa expands stablecoin capabilities on Visa Direct with zerohash collaboration
- B&G Foods: CFO Kenneth Keller to Retire >BGS
- Southwest Gas 2Q EPS 58c >SWX
- B&G Foods Announces Retirement Of CEO And Selection Of Successor >BGS
- Southwest Gas 2Q Net $42.1M >SWX
- Icahn Enterprises 2Q Loss/Shr 52c >IEP
- SmartRent 2Q Loss $5.64M >SMRT
- Global Ship Lease 2Q Rev $198.7M >GSL
- Avnet 4Q EPS $1.49 >AVT
- Avnet 4Q Adj EPS $2.28 >AVT
- US Dollar: Consolidation view into ISM and payrolls – BBH
- The long-term US Treasury yields continue to decline as the market bets on the implementation of the Hormuz Agreement.
- Shopify (SHOP.US) shares rose 33.8% in U.S. pre-market trading after its third-quarter revenue outlook exceeded market expectations. Shopify stated that it expects its revenue to achieve a "growth rate in the low 30% range." This rate will surpass Wall Street's previous expectation of 27% and means the company's revenue growth will exceed 30% for six consecutive quarters. Analyst Anurag Rana noted in a report that rising artificial intelligence costs were initially expected to compress profit m
- Brent: Price slips on Hormuz deal hopes – Rabobank
- New York Times Posts Higher 2Q Revenue, as Subscriber Growth Slows
- Stack Capital Group 2Q Book Value Per Share C$20.25 >STCK.T
- Stack Capital Group 2Q Total Book Value C$313M >STCK.T
- CVS Health Health Care Benefits Segment's 2Q Medical Benefit Ratio 87.4% >CVS
- CVS Health: New Collaboration With Eli Lilly Will Provide Eligible Zepbound and Foundayo Patients Additional Access Point at CVS Pharmacy Through CVS Health App >CVS
- CVS Health: Enhances Direct-To-Consumer Weight Management Offerings to Improve Access, Affordability, Care and Support for GLP-1 Medications >CVS
- CVS Health Updates 2026 Cash Flow From Operations Guidance to at Least $11.5B From at Least $9.5B >CVS
- CVS Health Sees 2026 Total Revenue of at Least $414B >CVS
- CVS Health Increasing Full-Year 2026 EPS, Adj EPS and Cash Flow From Operations Guidance to Reflect Increases in Health Care Benefits and Pharmacy & Consumer Wellness Segments >CVS
- CVS Health 2Q Prescriptions Filled Rose 4.3% on 30-Day Equivalent Basis >CVS
- Dynatrace 1Q EPS 12c >DT
- BorgWarner Sees FY EPS $4.72-EPS $4.94 >BWA
- BorgWarner 2Q EPS $1.34 >BWA
- BorgWarner Sees FY Sales $14B-$14.3B >BWA
- CVS Health 2Q EPS $2.31 >CVS
- CVS Health 2Q Rev $106.1B >CVS
- CVS Health Raises 2026 View To Adj EPS $7.90-Adj EPS $8.10 Vs Prior Guidance $7.30-$7.50 >CVS
- CVS Health 2Q Same-Store Prescription Volume Rose 7% >CVS
- CVS Health: 2Q Health Services Segment Rev Rose Primarily Driven by Pharmacy Drug Mix and Brand Inflation, Partially Offset by Continued Pharmacy Client Price Improvements >CVS
- CVS Health: 2Q Health Care Benefits Segment Rev Rose Primarily Driven by Increase in Govt Business, Partially Offset by Decline as Result of CO's Exit of Individual Exchange Business in 2026 >CVS
- CVS Health: 2Q Adjusted EPS Rose Primarily Due to Improved Adjusted Operating Income in Health Care Benefits Segment >CVS
- CVS Health 2Q Pharmacy & Consumer Wellness Segment Revenue Rose Slightly >CVS
- CVS Health 2Q Healthcare Benefits Segment Revenue Up 3.5% >CVS
- CVS Health Raises 2026 View To EPS $6.84-EPS $7.04 Vs Prior Guidance $6.24-$6.44 >CVS
- CVS Health 2Q Same-Store Sales Up 2.6% >CVS
- CVS Health 2Q Pharmacy Same-Store Sales Up 2.9% >CVS
- CVS Health 2Q Health Services Segment Revenue $51.8B >CVS
- CVS Health 2Q Health Services Segment Revenue Up 11.5% >CVS
- Ridgepost Capital 2Q Adj EPS 24c >RPC
- Edgewell Personal Care Adjusts 2026 View To EPS 0c-EPS 20c >EPC
- Ridgepost Capital 2Q EPS 6c >RPC
- Ecovyst Raises 2026 Adjusted EBITDA to $195M- $207M >ECVT
- Primo Brands 2Q Adj EPS 37c >PRMB
- Ecovyst Previous Adj EBITDA Guidance Was $180M$>ECVT
- Primo Brands Sees 2026 Net Sales Growth of 2%-4% >PRMB
- Edgewell Personal Care Narrows 2026 Reported Net Sales to Up 1.3%-1.8%>EPC
- Louisiana-Pacific Sees 2026 Siding Net Sales $1.65B-$1.67B >LPX
- Northwest Natural 2026 EPS Seen in Upper Half of Guidance Range of $2.95-$3.15 >NWN
- Correct: Ecovyst: Previous Sales Guidance Was $890M-$970M >ECVT
- Louisiana-Pacific Sees 3Q Siding Net Sales $460M-$470M >LPX
- Ecovyst: Previous Sales Guidance Was $890M$>ECVT
